DellaCamera Capital Management - Investor Profile
Primary Address: | Investor Information: | |
| 461 Fifth Avenue | Total AUM ($MM): | Login to Access |
| New York, NY 10017 | Equity AUM ($MM): | Login to Access |
| Phone: Login to Access | Investment Style: | Login to Access |
| Fax: Login to Access | Orientation: | Login to Access |
| Investor Type: | Login to Access | |
Institutional Investor Background
DellaCamera Capital Management (DCM) is a global hedge fund that was founded by Chief Investment Officer Ralph DellaCamera, Jr. in 2005. From 2002 to 2005, Mr. DellaCamera was a Managing...
Login now or Register for a Free Account to access full Institutional Investor Background
Investor Regional and/or Country Focus: Global
Founders and Key Executives of DellaCamera Capital Management: Ralph DellaCamera; Andrew J. Kurtz; Richard Mansouri
Entities related to DellaCamera Capital Management: DellaCamera Capital Partners LP; DellaCamera Capital Advisors; DellaCamera Options Inc
*Denotes that the person or entity is no longer related to the firm.
See Investor Roadshow Profile for Comprehensive Investment Strategy and Complete Holdings
Articles Related to DellaCamera Capital Management
Shareholder Activist Update: Riley Investment Management & DellaCamera Capital Management | ||
| Date: March 4th, 2010 | ||
| Since late January, Riley Investment Management has purchased and currently holds approximately 482,543 shares or 7% of shares outstanding of WPCS International... | ||
Login now or Register for a Free Account to access all Related Articles | ||
Icahn Increases Stakes in Biotech Bets | ||
| Date: January 29th, 2009 | ||
| SEC filings revealed today that Carl Icahn has increased his stakes in Amylin (AMLN) to 12.1 million shares (8.8%) and Enzon Pharmaceuticals (ENZN) to... | ||
Login now or Register for a Free Account to access all Related Articles | ||
Enzon Pharma folds under pressure from shareholder activists | ||
| Date: August 11th, 2008 | ||
| Today, Enzon Pharmaceuticals (ENZN) announced that it would give into shareholder activists' demands and try to sell all or parts of its commercial business,... | ||
Login now or Register for a Free Account to access all Related Articles | ||
